Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study.

Rowland GW, Schwartz GG, John EM, Ingles SA.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):16-24. doi: 10.1158/1055-9965.EPI-12-0922-T. Epub 2012 Nov 5.

2.

Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype.

Rowland GW, Schwartz GG, John EM, Ingles SA.

J Bone Miner Res. 2012 Jan;27(1):187-94. doi: 10.1002/jbmr.505.

3.

Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.

Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS Jr, Whittemore AS.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1325-30.

4.

Dietary factors and risks for prostate cancer among blacks and whites in the United States.

Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, Schoenberg JB, Silverman DT, Brown LM, Pottern LM, Liff J, Schwartz AG, Fraumeni JF Jr, Hoover RN.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):25-34.

5.

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.

Li H, Stampfer MJ, Hollis JB, Mucci LA, Gaziano JM, Hunter D, Giovannucci EL, Ma J.

PLoS Med. 2007 Mar;4(3):e103.

6.

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA.

J Natl Cancer Inst. 1997 Jan 15;89(2):166-70.

PMID:
8998186
7.

VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men.

Torkko KC, van Bokhoven A, Mai P, Beuten J, Balic I, Byers TE, Hokanson JE, Norris JM, Barón AE, Lucia MS, Thompson IM, Leach RJ.

Clin Cancer Res. 2008 May 15;14(10):3223-9. doi: 10.1158/1078-0432.CCR-07-4894.

8.

Dietary calcium, vitamin D, VDR genotypes and colorectal cancer.

Slattery ML, Neuhausen SL, Hoffman M, Caan B, Curtin K, Ma KN, Samowitz W.

Int J Cancer. 2004 Sep 20;111(5):750-6. Erratum in: Int J Cancer. 2004 Oct 10;111(6):983.

9.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

10.

Race and BMI modify associations of calcium and vitamin D intake with prostate cancer.

Batai K, Murphy AB, Ruden M, Newsome J, Shah E, Dixon MA, Jacobs ET, Hollowell CM, Ahaghotu C, Kittles RA.

BMC Cancer. 2017 Jan 19;17(1):64. doi: 10.1186/s12885-017-3060-8.

11.

Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.

Nelson SM, Batai K, Ahaghotu C, Agurs-Collins T, Kittles RA.

Nutrients. 2016 Dec 28;9(1). pii: E12. doi: 10.3390/nu9010012.

12.

Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly.

Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, Pols HA, Uitterlinden AG.

J Bone Miner Res. 2003 Sep;18(9):1632-41.

13.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

PMID:
17925536
14.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

PMID:
19726753
15.

Association of prostate cancer with vitamin D receptor gene polymorphism.

Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA.

Cancer Res. 1996 Sep 15;56(18):4108-10.

16.

Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations.

Jenab M, McKay J, Bueno-de-Mesquita HB, van Duijnhoven FJ, Ferrari P, Slimani N, Jansen EH, Pischon T, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Engel P, Kaaks R, Linseisen J, Boeing H, Fisher E, Trichopoulou A, Dilis V, Oustoglou E, Berrino F, Vineis P, Mattiello A, Masala G, Tumino R, Vrieling A, van Gils CH, Peeters PH, Brustad M, Lund E, Chirlaque MD, Barricarte A, Suárez LR, Molina E, Dorronsoro M, Sala N, Hallmans G, Palmqvist R, Roddam A, Key TJ, Khaw KT, Bingham S, Boffetta P, Autier P, Byrnes G, Norat T, Riboli E.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2485-91. doi: 10.1158/1055-9965.EPI-09-0319. Epub 2009 Aug 25.

17.

The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density.

Kiel DP, Myers RH, Cupples LA, Kong XF, Zhu XH, Ordovas J, Schaefer EJ, Felson DT, Rush D, Wilson PW, Eisman JA, Holick MF.

J Bone Miner Res. 1997 Jul;12(7):1049-57.

18.

Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor.

Schwartz GG, John EM, Rowland G, Ingles SA.

Cancer Biol Ther. 2010 Jun 15;9(12):994-9. Epub 2010 Jun 4.

PMID:
20364112
19.

CDX2 VDR polymorphism and colorectal cancer.

Slattery ML, Herrick J, Wolff RK, Caan BJ, Potter JD, Sweeney C.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2752-5.

20.

5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites.

Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C, Sandler R.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1611-21.

Supplemental Content

Support Center